June 2016

Shugoll Research On the Record
On the Record is Shugoll Research's regular examination of marketing research in Washington, DC and around the country. Join us online to browse previous editions of On The Record and for further information on our services.

2016 PMRG Connect


The PMRG CONNECT Conference at the Washington, DC National Harbor on May 1st-3rd provided insight on the convergence of art and science in marketing research. Attendees represented all aspects of the industry: pharmaceutical manufacturers, researchers, data collectors and vendors. We had the opportunity to attend educational sessions on topics such as:
  • Disruptive thinking
  • Making research more actionable for your client
  • How the Presidential election may impact health care reform
  • Creativity in market research
We also enjoyed networking in the conference’s exhibit hall, where Shugoll Research was proud to join 62 other exhibitors to help showcase the diversity of insight, acumen and experience in health care marketing research today.


Connect With Us:

Connect with Linked In Connect on Facebook Follow Us on Twitter

The Sunshine Act

The Physician Payments Sunshine Act was enacted to bring transparency to financial relationships between pharmaceutical manufacturers and the health care providers that are prescribing and using their products. The intent of the act is to literally shine a light on any potential conflicts of interest that exist between health care practitioners and manufacturers, with the ultimate goal being to bring down the cost of health care.

The Act was originally introduced in 2007 by Senators Chuck Grassley and Herb Kohl, but it failed to pass. It was then included and passed into law in 2010 as part of the Patient Protection and Affordable Care Act, also known as Obamacare. The act requires pharmaceutical and medical device manufacturers that participate in federal health care programs such as Medicare, Medicaid and the State Children’s Health Insurance Program to report financial gifts, payments and other items of value given to physicians and teaching hospitals.

How does this impact market research? It has virtually no impact as long as market research best practices are followed. Payments made to health care professionals for participating in marketing research are excluded from reporting requirements as long as:

  • Payments are made by research companies rather than directly by pharmaceutical and medical device manufacturers
  • The manufacturer is “unaware of the identity of the covered participant”. In other words, research firms can’t reveal the identity of study participants to the manufacturer/sponsor of the research.

CASRO, MRA and PMRG published a position paper on the Sunshine Act, and it is available for download at: http://bit.ly/1WWDZ4c

Shugoll Research has been conducting research for pharmaceutical, biotech and medical device companies, as well as healthcare systems and third party payors for well over 50 years. Studies explore the attitudes and behaviors of health care professionals, patients and caregivers. We have long been active participants in grassroots efforts along with MRA, CASRO and PMRG to lobby for exclusions for market research honoraria payments in the Sunshine Act. We also worked very closely with these organizations to lobby the DC Board of Pharmacy to establish exclusions to the reporting requirements for marketing research honoraria that were initially part of the DC Access Rx Act of 2004. These exclusions basically mirror those of the Sunshine Act for payments of market research honoraria to physicians licensed in DC.

Shugoll Research’s expertise in medical research and the legislative environment that impacts the marketing research profession is highly valued by its clients. Please consider Shugoll Research and the DC market for your next pharmaceutical, biotechnology, medical device or other healthcare project. We guarantee you will be in good hands.

Tel: (301) 656-0310
Fax: (301) 657-9051